BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 6342957)

  • 1. Placebo-controlled trial of a combination of bemetizide and triamterene ('Hypertane') in mild or moderate hypertension.
    Hornung R; Keiso H; Raftery EB; Whittington JR
    Curr Med Res Opin; 1983; 8(6):425-33. PubMed ID: 6342957
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative clinical trial of bemetizide/triamterene and cyclopenthiazide/potassium chloride combinations in patients with mild to moderate hypertension.
    Wray R; Benton KG; Whitehill D; Wright B; Weener W; Whittington JR
    Curr Med Res Opin; 1983; 8(9):665-74. PubMed ID: 6365467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Long-term treatment of hypertension with a beta blocker-diuretic combination].
    Hoffmann J; Grund R; Schrey A
    ZFA (Stuttgart); 1983 Nov; 59(31):1773-7. PubMed ID: 6659669
    [No Abstract]   [Full Text] [Related]  

  • 4. [Multicentric trial of a bemetizide and triamterene combination in hypertonics].
    Schrey A; Schmidt G; Haase W
    Med Welt; 1978 Oct; 29(43):1691-6. PubMed ID: 362111
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical experience with a new combination formulation of triamterene and hydrochlorothiazide (Maxzide) in patients with mild to moderate hypertension.
    Williams RL; Clark T; Blume CD
    Am J Med; 1984 Nov; 77(5A):62-6. PubMed ID: 6388328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. I.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Applin WJ; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):133-9. PubMed ID: 6376207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of a potassium-sparing combination of chlorthalidone and triamterene in the control of mild and moderate hypertension. II.
    Webb EL; Godfrey JC; Gertel A; Costello RJ; Cooper WH; Zisblatt M; Vukovich RA; Neiss ES
    J Int Med Res; 1984; 12(3):140-6. PubMed ID: 6376208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experiences with a combination of bemetizide and triamterene in the ambulatory treatment of hypertension. Report of a multicentric study].
    Schrey A; Schmidt G; Ziegler WJ
    Med Welt; 1978 Dec; 29(49):1936-43. PubMed ID: 732567
    [No Abstract]   [Full Text] [Related]  

  • 9. [Ambulant treatment of hypertension with cardiotensin (author's transl)].
    Diehm C; Mörl H; Müller-Bühl U; Schrey A; Grund R
    MMW Munch Med Wochenschr; 1981 Sep; 123(39):1458-62. PubMed ID: 6792535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of hypertension with a drug combination, consisting of bemetizide, triamterene, dihydralazine and bupranolol (author's transl)].
    Gasser RW; Brandstetter G; Skrabal F
    Wien Klin Wochenschr; 1982 Jan; 94(1):25-8. PubMed ID: 7080491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Long-term efficacy and side effect profile of a low-dose bemetizid-triamterene combination in patients with essential hypertension].
    Fritschka E; Schmidt G
    Med Klin (Munich); 1989 Nov; 84(11):526-33. PubMed ID: 2512474
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of two combined diuretics in the treatment of essential hypertension.
    Verhiest W; Baehre M; Volkers P
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):342-5. PubMed ID: 2674028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrochlorothiazide and triamterene with sustained-release oxprenolol in the treatment of hypertension.
    Backhouse CI; Rowley-Jones D; Spencer-Mills L
    Curr Med Res Opin; 1986; 10(3):196-202. PubMed ID: 3731824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potassium-sparing effects of triamterene in the treatment of hypertension.
    Spiekerman RE; Berge KG; Thurber DL; Gedge SW; McGuckin WF
    Circulation; 1966 Sep; 34(3):524-31. PubMed ID: 5332122
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypertension in mild kidney insufficiency].
    Schrey A; Hartmann H; Jutzler GA; Grund R; Forst HT
    Ther Ggw; 1982 Aug; 121(8):465-75. PubMed ID: 6753222
    [No Abstract]   [Full Text] [Related]  

  • 16. [Treatment of hypertension in private practice. Study using cardiotensin].
    Schrey A; von Batky ES; Grund R
    ZFA (Stuttgart); 1982 Jul; 58(19):1069-74. PubMed ID: 6753393
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of hypertension with bupranolol, bemetizide and triamterene].
    Lederle RM; Klaus D
    Dtsch Med Wochenschr; 1982 Oct; 107(42):1587-91. PubMed ID: 7128471
    [No Abstract]   [Full Text] [Related]  

  • 18. Comparison of the efficacy of furosemide with two furosemide-triamterene combinations in the treatment of cardiac insufficiency.
    Saarimaa H; Ojasalo T
    J Int Med Res; 1985; 13(4):236-40. PubMed ID: 4043516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of low-renin essential hypertension. Comparison of spironolactone and a hydrochlorothiazide-triamterene combination.
    Douglas JG; Hollifield JW; Liddle GW
    JAMA; 1974 Feb; 227(5):518-21. PubMed ID: 4589187
    [No Abstract]   [Full Text] [Related]  

  • 20. Bioavailability of bemetizide and triamterene from a combination formulation.
    Brodie RR; Chasseaud LF; Darragh A; Taylor T; Walmsley LM
    Biopharm Drug Dispos; 1982; 3(4):361-70. PubMed ID: 7159690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.